V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16635895 | 330010684 | EWM01 | 800 | null | 1 | 2014-05-13 | RITUXIMAB | 330020482 | 330012859 | 330010687 |
| 16635896 | 330010684 | EYG01 | 800 | X721 | 1 | 2014-05-13 | RITUXIMAB | 330020482 | 330012859 | 330010687 |
| 16635897 | 330010684 | EJN | 100 | X721 | 1 | 2014-05-13 | NOT CHEMO | 330020482 | 330012859 | 330010687 |
| 16635898 | 330010684 | EOI | 2 | X724 | 1 | 2014-05-20 | MIFAMURTIDE | 330020482 | 330012859 | 330010687 |
| 16635899 | 330010684 | ETG | 2 | null | 1 | 2014-05-21 | MIFAMURTIDE | 330020482 | 330012859 | 330010687 |
| 16635900 | 330010684 | EUZ | 20 | X721 | 1 | 2014-05-22 | NOT CHEMO | 330020482 | 330012859 | 330010687 |
| 16635901 | 330010684 | ERA20 | 60 | X721 | 1 | 2014-05-22 | CISPLATIN | 330020482 | 330012859 | 330010687 |
| 16635902 | 330010686 | EEI00 | 3500 | X721 | 1 | 2017-05-22 | IFOSFAMIDE | 330020501 | 330005448 | 330010689 |
| 16635903 | 330010686 | EEI00 | 220 | X729 | 1 | 2017-05-23 | ETOPOSIDE | 330020501 | 330005448 | 330010689 |
| 16635904 | 330010688 | EEI00 | 180 | X729 | 1 | 2015-10-19 | ETOPOSIDE | 330020527 | 330005452 | 330010691 |
| 16635905 | 330010688 | EEI00 | 120 | X729 | 1 | 2015-10-19 | ETOPOSIDE | 330020527 | 330005452 | 330010691 |
| 16635906 | 330010688 | EEX02 | 5040 | null | 1 | 2015-10-20 | IFOSFAMIDE | 330020527 | 330005452 | 330010691 |
| 16635907 | 330010688 | EWR09 | 1000 | X722 | 2 | 2015-10-20 | NOT CHEMO | 330020527 | 330005452 | 330010691 |
| 16635908 | 330010690 | ETG | 0 | X729 | 1 | 2014-01-25 | IFOSFAMIDE | 330020552 | 330005454 | 330010693 |
| 16635909 | 330010690 | EU8 | 1800 | X724 | 1 | 2014-01-25 | IFOSFAMIDE | 330020552 | 330005454 | 330010693 |
| 16635910 | 330010690 | EE813 | 5900 | X724 | 1 | 2014-01-25 | IFOSFAMIDE | 330020552 | 330005454 | 330010693 |
| 16635911 | 330010690 | EGC04 | 175 | X722 | 1 | 2014-02-23 | BENDAMUSTINE | 330020552 | 330005454 | 330010693 |
| 16635912 | 330010691 | ETG | 190 | X724 | 1 | 2017-11-26 | ETOPOSIDE | 330020556 | 330005456 | 330010694 |
| 16635913 | 330010691 | EE813 | 3000 | null | 1 | 2017-11-27 | IFOSFAMIDE | 330020556 | 330005456 | 330010694 |
| 16635914 | 330010691 | EEX02 | 4800 | null | 1 | 2017-11-27 | IFOSFAMIDE | 330020556 | 330005456 | 330010694 |
| 16635915 | 330010691 | EGX01 | 800 | X724 | 1 | 2017-11-27 | RITUXIMAB | 330020556 | 330005456 | 330010694 |
| 16635916 | 330010691 | EOQ01 | 0 | X724 | 2 | 2017-11-27 | NOT CHEMO | 330020556 | 330005456 | 330010694 |
| 16635917 | 330010691 | EAF01 | 10 | null | 1 | 2017-11-28 | NOT CHEMO | 330020556 | 330005456 | 330010694 |
| 16635918 | 330010691 | EE813 | 3.68 | X729 | null | 2017-11-28 | MIFAMURTIDE | 330020556 | 330005456 | 330010694 |
| 16635919 | 330010691 | EGU02 | 14 | null | 1 | 2017-12-26 | METHOTREXATE | 330020556 | 330005456 | 330010694 |
| 16635920 | 330010691 | EW100 | 125 | X721 | 1 | 2017-12-26 | NOT CHEMO | 330020556 | 330005456 | 330010694 |
| 16635921 | 330010691 | EKJ | 77 | X721 | 1 | 2017-12-26 | CISPLATIN | 330020556 | 330005456 | 330010694 |
| 16635922 | 330010691 | ES4DU | 82 | null | 1 | 2018-01-02 | CISPLATIN | 330020556 | 330005456 | 330010694 |
| 16635923 | 330010691 | ETD02 | 600 | X724 | 1 | 2018-01-03 | CARBOPLATIN | 330020556 | 330005456 | 330010694 |
| 16635924 | 330010692 | EUDJC | 2800 | X724 | 1 | 2014-06-30 | IFOSFAMIDE | 330020565 | 330005457 | 330010695 |
| 16635925 | 330010692 | EEI00 | 4500 | X729 | 1 | 2014-06-30 | IFOSFAMIDE | 330020565 | 330005457 | 330010695 |
| 16635926 | 330010692 | EEI00 | 30 | null | 1 | 2014-06-30 | MESNA | 330020565 | 330005457 | 330010695 |
| 16635927 | 330010692 | EPQ | 0.9 | null | 1 | 2014-06-30 | NOT CHEMO | 330020565 | 330005457 | 330010695 |
| 16635928 | 330010693 | ETG | 2700 | null | 1 | 2018-04-23 | IFOSFAMIDE | 330020590 | 330005461 | 330010696 |
| 16635929 | 330010693 | ERA20 | 500 | X729 | 1 | 2018-04-23 | NOT CHEMO | 330020590 | 330005461 | 330010696 |
| 16635930 | 330010694 | ETG | 150 | null | 1 | null | ETOPOSIDE | 330020602 | 330008981 | 330010697 |
| 16635931 | 330010694 | EX950 | 100 | X724 | 1 | null | ETOPOSIDE | 330020602 | 330008981 | 330010697 |
| 16635943 | 330010697 | EEI00 | 240 | X729 | 1 | 2014-01-29 | ETOPOSIDE | 330020635 | 330005468 | 330010700 |
| 16635944 | 330010697 | EEI00 | 100 | X729 | 1 | 2014-01-29 | ETOPOSIDE | 330020635 | 330005468 | 330010700 |
| 16635945 | 330010697 | EEX02 | 5600 | null | 1 | 2014-01-31 | IFOSFAMIDE | 330020635 | 330005468 | 330010700 |
| 16635946 | 330010697 | EQH01 | 157.5 | 722 | 1 | 2014-01-31 | BENDAMUSTINE | 330020635 | 330005468 | 330010700 |
| 16635947 | 330010697 | EKJ | 125 | null | 1 | 2014-01-31 | BENDAMUSTINE | 330020635 | 330005468 | 330010700 |
| 16635948 | 330010697 | EOI | 288 | X721 | 1 | 2014-01-31 | PACLITAXEL | 330020635 | 330005468 | 330010700 |
| 16635949 | 330010697 | ED301 | 2.96 | X723 | 1 | 2014-02-07 | MIFAMURTIDE | 330020635 | 330005468 | 330010700 |
| 16635950 | 330010697 | EGU08 | 64 | X721 | 1 | 2014-02-08 | DOXORUBICIN | 330020635 | 330005468 | 330010700 |
| 16635951 | 330010697 | ERS12 | 100 | X721 | 1 | 2014-02-09 | NOT CHEMO | 330020635 | 330005468 | 330010700 |
| 16635954 | 330010699 | EGU02 | 6 | null | 1 | 2017-03-24 | IFOSFAMIDE | 330020665 | 330005471 | 330010702 |
| 16635955 | 330010700 | EEI00 | 4 | X721 | 1 | 2018-06-13 | STEROID | 330020669 | 330005474 | 330010703 |
| 16635956 | 330010700 | EE813 | 210 | X724 | 1 | 2018-06-13 | ETOPOSIDE | 330020669 | 330005474 | 330010703 |
| 16635957 | 330010700 | EOI | 1.6 | null | 1 | 2018-06-13 | MESNA | 330020669 | 330005474 | 330010703 |